📑NHS Framework for the NHS North of England Region, Branded Medicines - Tranche B, Cytokine Modulators and other Monoclonal Antibodies, and Fondaparinux
Procurement process summary
This process is to purchase NHS Framework for the NHS North of England Region, Branded Medicines - Tranche B, Cytokine Modulators and other Monoclonal Antibodies, and Fondaparinux.
This contract was awarded by 🇬🇧 The NHS Commissioning Board (operating under the name of NHS England) for an amount of GBP 514,043,196 to 1 supplier. It was published on 2019-10-07 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇬🇧 The NHS Commissioning Board (operating under the name of NHS England) Buying unitnot reported Publication date2019-10-07 Contest statusnot reported DescriptionNHS Framework for the NHS North of England Region, Branded Medicines - Tranche B, Cytokine Modulators and other Monoclonal Antibodies, and Fondaparinux.Offer reference number: CM/PHR/16/5527CM/PHR/16/5527/01 -- Tranche B: 1.3.2020 to 28.2.2022 with an option to extend (at the authority's discretion) for a period or periods up to a total of 24 months.CM/PHR/16/5527/02 - Annual tranche -- cytokine modulators and other monoclonal antibodies -- 1.3.2020 to 28.2.2021 with an option to extend (at the authority's discretion) for a period or periods up to a total of 12 months.CM/PHR/16/5527/03 - NHS framework agreement for Fondaparinux -- London - 1.3.2020 - 31.8.2021, South of England - 1.3.2020 - 31.8.2020, Midlands and East - 1.3.2020 - 28.2.2021, all with an option to extend (at the authority's discretion) for a period or periods up to a total of 24 months.Awards
This award was granted to Janssen-Cilag Ltd by The NHS Commissioning Board (operating under the name of NHS England) for an amount of GBP 514,043,196. The procurement process was conducted through open for the category of goods. This is award number 10.
This contract has multiple awards. This is award number 10. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇬🇧 Janssen-Cilag Ltd | GBP 514,043,196 | 10 |
Market context and opportunities
The execution of this contract allows the entity The NHS Commissioning Board (operating under the name of NHS England) to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUK_ocds-70d2nz-1a0934fa-ca1d-4bd1-9edb-d5f9f8245e17-award-10Publication date2019-10-07Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
